Intervention not reported
Improvement in symptoms, reported by the child or by their parents/carers, preferably measured by a validated tool, at three months (± one month) after start of treatment · children with blepharokeratoconjunctivitis
1 finding from 1 review
Intervention not reported
Elimination of all clinical signs of ocular surface inflammation ('complete success'), preferably measured by a composite grading system, at three months (± one month) after start of treatment · children with blepharokeratoconjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Improvement of clinical signs of ocular surface inflammation ('partial success'), preferably measured by a composite grading system, at three months (± one month) after start of treatment · children with blepharokeratoconjunctivitis
1 finding from 1 review
no estimate extracted
137 participants
Very low
Intervention not reported
Change from baseline in best corrected visual acuity in affected eye(s) in logMAR · children with blepharokeratoconjunctivitis
1 finding from 1 review
Intervention not reported
Uncontrolled or poorly controlled disease progression due to treatment failure, at three months (± one month) after start of treatment · children with blepharokeratoconjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse effects of medication, at any time during treatment · children with blepharokeratoconjunctivitis
1 finding from 1 review
Intervention not reported
Quality of life · children with blepharokeratoconjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found